These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30659956)

  • 1. Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes.
    Zhao X; Xue J; Xie M
    Exp Gerontol; 2019 May; 119():7-13. PubMed ID: 30659956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
    Zhao X; Xue J; Wang XL; Zhang Y; Deng M; Xie ML
    Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osthole inhibits inflammatory cytokine release through PPARα/γ-mediated mechanisms in LPS-stimulated 3T3-L1 adipocytes.
    Wang XL; Shang X; Cui Y; Zhao X; Zhang Y; Xie ML
    Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):185-92. PubMed ID: 25689951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.
    Zhao X; Wang F; Zhou R; Zhu Z; Xie M
    Inflammopharmacology; 2018 Apr; 26(2):425-433. PubMed ID: 28236037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells.
    Huang WC; Liao PC; Huang CH; Hu S; Huang SC; Wu SJ
    Biomed Pharmacother; 2017 Jul; 91():78-87. PubMed ID: 28448873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
    Pant A; Rondini EA; Kocarek TA
    Toxicol Appl Pharmacol; 2019 Feb; 365():61-70. PubMed ID: 30611723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes.
    Wu L; Wang Y; Chi G; Shen B; Tian Y; Li Z; Han L; Zhang Q; Feng H
    J Cell Physiol; 2019 Nov; 234(11):19785-19798. PubMed ID: 30937936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats.
    Qi ZG; Zhao X; Zhong W; Xie ML
    Pharm Biol; 2016; 54(5):882-8. PubMed ID: 26455539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation.
    Sun B; Jia Y; Hong J; Sun Q; Gao S; Hu Y; Zhao N; Zhao R
    J Agric Food Chem; 2018 Jul; 66(29):7633-7642. PubMed ID: 29961332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osthole regulates TGF-β1 and MMP-2/9 expressions via activation of PPARα/γ in cultured mouse cardiac fibroblasts stimulated with angiotensin II.
    Chen R; Xue J; Xie M
    J Pharm Pharm Sci; 2013; 16(5):732-41. PubMed ID: 24393555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
    Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation.
    Tian Y; Feng H; Han L; Wu L; Lv H; Shen B; Li Z; Zhang Q; Liu G
    Front Immunol; 2018; 9():147. PubMed ID: 29467759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.
    Zhang Y; Xie M; Xue J; Gu Z
    Planta Med; 2007 Jul; 73(8):718-24. PubMed ID: 17611927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines.
    Fang X; Zou S; Zhao Y; Cui R; Zhang W; Hu J; Dai J
    Arch Toxicol; 2012 Oct; 86(10):1515-25. PubMed ID: 22648072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.